Skip to main content

Current Breast Cancer Reports

Ausgabe 3/2012

Inhalt (8 Artikel)

Invited Commentary

Is HER2 Through?

George W. Sledge Jr., Lida Mina, Anna Maria Storniolo

Open Access Invited Commentary

Analysis of Cyclin D1 in Breast Cancer: A Call to Arms

Nicholas P. Tobin, Jonas Bergh

Risk, Prevention, and Screening (MC Liu, Section Editor)

Options for Surgical Prophylaxis and Reconstruction

Benjamin J. Brown, Ali Al-Attar, Scott L. Spear

Open Access Risk, Prevention, and Screening (MC Liu, Section Editor)

Comparison of Random Periareolar Fine Needle Aspirate versus Ductal Lavage for Risk Assessment and Prevention of Breast Cancer

Abigail Hoffman, Rod Pellenberg, Catherine Ibarra Drendall, Victoria Seewaldt

Risk, Prevention, and Screening (MC Liu, Section Editor)

Prophylactic Mastectomy and Risk-Reducing Salpingo-oophorectomy in BRCA1/2 Mutation Carriers

Kara N. Maxwell, Susan M. Domchek

Risk, Prevention, and Screening (MC Liu, Section Editor)

Tamoxifen versus Raloxifene versus Exemestane for Chemoprevention

Laura Reimers, Katherine D. Crew

Risk, Prevention, and Screening (MC Liu, Section Editor)

Role of Mammography versus Magnetic Resonance Imaging for Breast Cancer Screening

Linei Urban, Cícero Urban

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.